Engineers Gate Manager’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Engineers Gate Manager’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,255	Closed	-$349K	–	2122
2023 Q1	$349K	Buy	+3,255	New	+$375K	0.01%	1164

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Engineers Gate Manager's RXDX Position: Q2 2023 in Review

Engineers Gate Manager sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 3,255 shares — an estimated $349K sold.

Engineers Gate Manager first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $349K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Engineers Gate Manager reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Engineers Gate Manager sold 3,255 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $349K.
Engineers Gate Manager first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Engineers Gate Manager's Prometheus Biosciences, Inc. Common Stock position peaked at $349K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Engineers Gate Manager's 13F filing for Q2 2023, filed 14 Aug 2023.